Intelligent Bio SolutionsINBS 
-11.69%24h
Intelligent Bio Solutions (INBS) Stock Overview
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
INBS Stock Information
Intelligent Bio Solutions (INBS) Price Chart
Intelligent Bio Solutions Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $2.19 | N/A |
| Market Cap | $183.34K | N/A |
| Shares Outstanding | 83.72K | 37.00% |
| Employees | 51.00 | N/A |
| Shareholder Equity | 3.69M | -43.67% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -0.02 | N/A |
| P/S Ratio | 0.15 | N/A |
| P/B Ratio | 0.05 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | -2.8925 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $1.26M | N/A |
| Earnings | -$10.66M | N/A |
| EPS | -126.96 | N/A |
| Earnings Yield | -57.97 | N/A |
| Gross Margin | 0.2599 | N/A |
| Operating Margin | -6.71 | N/A |
| Net income margin | -8.48 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $10.35M | N/A |
| Total Debt | $1.34M | N/A |
| Cash on Hand | $1.54M | N/A |
| Debt to Equity | $1.81 | 103.87% |
| Cash to Debt | $1.15 | N/A |
| Current Ratio | 0.6565 | -71.83% |
